RPL3 and colorectal carcinoma: To decipher the molecular mechanismsdriven by uL3 in drug response, we investigated the whole transcriptomeof the CRC cell line silenced for uL3 (uL3ΔHCT 116p53–/–), previously characterized for drug resistance,22 and the parental cell line (HCT 116p53–/–).